Why Novavax Stock Surged 14% on Friday

347
20
Favorite

Why Novavax Stock Surged 14% on Friday

Motley Fool2022-01-29

Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

347

Report

Comment（20）

愿我谦卑
·2022-02-03
以色列全族人接種？不怕未知後果可怕？！
Reply
Like
Report
Fold Replies
- greedy:
  人家以色列要打，而且诺瓦涨的主要原因还是跌太多了再加上fda申请
  2022-02-03
  Reply
  Report
Venus168
·2022-01-30
Good
Reply
1
Report
SPOT_ON
·2022-01-30
While stock last.. to run
Reply
3
Report
ping23
·2022-01-29
pls like
Reply
4
Report
Kiwii
·2022-01-29
hallo
Reply
3
Report
jilimi
·2022-01-29
👍
Reply
3
Report
Lenny Sari
·2022-01-29
Y
Reply
4
Report
dahae
·2022-01-29
Q
Reply
5
Report
XLMM
·2022-01-29
There should be more orders and approvals coming soon! Hope it drives the prices a lot more 🙂
Reply
4
Report
koolgal
·2022-01-29
The latest variant BA.2 is now spreading like wild fire across the world. The good news is that WHO has not said yet that it is a variant of concern. It is supposedly 1.5 times more easily spread than Omicron. It is good that Novavax is getting more attention as we need all the help we can get against Covid-19!
Reply
18
Report
Frosty4ever
·2022-01-29
Surprise $nvax is green.
Reply
2
Report
Grit100
·2022-01-29
Ok
Reply
1
Report
Gagnant10
·2022-01-29
Impress
Reply
1
Report
thammada
·2022-01-29
[Happy]
Reply
4
Report
chqngchang
·2022-01-29
[Smile]
Reply
4
Report
iamateh
·2022-01-29
wow
Reply
3
Report
blackant
·2022-01-29
Ok..
Reply
3
Report
FlorCheah
·2022-01-29
Wow
Reply
3
Report
Ahsiang
·2022-01-29
Like pls
Reply
5
Report
sinoob
·2022-01-29
Happy weekend! Come like like comment comment tqtq kam siah kam siah
Reply
8
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1188787478?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-29 10:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188787478","market":"us","top_or_hot":-1,"title":"Why Novavax Stock Surged 14% on Friday","media":"Motley Fool","content":"<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Source Link</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","article_id":"1188787478","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","pubTimestamp":1643423060,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"translate_title":"为什么诺瓦瓦克斯医药股票周五大涨14%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"NVAX":0.9,"PFE":0.9},"content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":633105438,"gmtCreate":1643818270745,"gmtModify":1676532674550,"author":{"id":"3556066209592208","authorId":"3556066209592208","name":"愿我谦卑","avatar":"https://static.tigerbbs.com/f64b1d0433d2b11b36ef2f5f6301308c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3556066209592208","idStr":"3556066209592208"},"htmlText":"以色列全族人接種？不怕未知後果可怕？！","listText":"以色列全族人接種？不怕未知後果可怕？！","text":"以色列全族人接種？不怕未知後果可怕？！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/633105438","repostId":1188787478,"repostType":2,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7226502,"gmtCreate":1643834476090,"gmtModify":1663239722038,"authorId":3546578550627869,"author":{"id":3546578550627869,"idStr":"3546578550627869","authorId":3546578550627869,"name":"greedy","avatar":"https://static.tigerbbs.com/8972621cf9ab3bdbd331853d1d060d39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":633105438,"type":1,"supId":0,"prevId":0,"content":"人家以色列要打，而且诺瓦涨的主要原因还是跌太多了再加上fda申请","text":"人家以色列要打，而且诺瓦涨的主要原因还是跌太多了再加上fda申请","html":"人家以色列要打，而且诺瓦涨的主要原因还是跌太多了再加上fda申请"}],"langContent":"CN"},{"id":633034423,"gmtCreate":1643547542083,"gmtModify":1676532666327,"author":{"id":"4087185180550510","authorId":"4087185180550510","name":"Venus168","avatar":"https://community-static.tradeup.com/news/4896107829fe32fd3a83e066df1681a0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087185180550510","idStr":"4087185180550510"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/633034423","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9093997190,"gmtCreate":1643494733770,"gmtModify":1676533824721,"author":{"id":"3582922989777578","authorId":"3582922989777578","name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3582922989777578","idStr":"3582922989777578"},"htmlText":"While stock last.. to run","listText":"While stock last.. to run","text":"While stock last.. to run","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093997190","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9093046618,"gmtCreate":1643470147871,"gmtModify":1676533823794,"author":{"id":"3574521189147374","authorId":"3574521189147374","name":"ping23","avatar":"https://static.tigerbbs.com/c38fda829a130d716804cbae538a7cb8","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3574521189147374","idStr":"3574521189147374"},"htmlText":"pls like","listText":"pls like","text":"pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093046618","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9093054707,"gmtCreate":1643469012258,"gmtModify":1676533823524,"author":{"id":"3579735899676546","authorId":"3579735899676546","name":"Kiwii","avatar":"https://community-static.tradeup.com/news/c31b2d8301c0e367c9f368c3506dad90","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3579735899676546","idStr":"3579735899676546"},"htmlText":"hallo","listText":"hallo","text":"hallo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093054707","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9093054434,"gmtCreate":1643469009405,"gmtModify":1676533823535,"author":{"id":"4089552822641240","authorId":"4089552822641240","name":"jilimi","avatar":"https://static.tigerbbs.com/0e2467f98553dd418c9f7848124557f3","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"4089552822641240","idStr":"4089552822641240"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093054434","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9093027261,"gmtCreate":1643466559664,"gmtModify":1676533823306,"author":{"id":"4101864922461960","authorId":"4101864922461960","name":"Lenny Sari","avatar":"https://static.tigerbbs.com/24348ddf29c764e6bd01343eba2e92e4","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"4101864922461960","idStr":"4101864922461960"},"htmlText":"Y","listText":"Y","text":"Y","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093027261","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9093082623,"gmtCreate":1643458098102,"gmtModify":1676533822712,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3560092322694803","idStr":"3560092322694803"},"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093082623","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9093010536,"gmtCreate":1643450957824,"gmtModify":1676533822339,"author":{"id":"4100909250192760","authorId":"4100909250192760","name":"XLMM","avatar":"https://community-static.tradeup.com/news/5fd3a75ea7ccf88aca493e34c270e676","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4100909250192760","idStr":"4100909250192760"},"htmlText":"There should be more orders and approvals coming soon! Hope it drives the prices a lot more 🙂","listText":"There should be more orders and approvals coming soon! Hope it drives the prices a lot more 🙂","text":"There should be more orders and approvals coming soon! Hope it drives the prices a lot more 🙂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093010536","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9093090033,"gmtCreate":1643443040675,"gmtModify":1676533821738,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3559581955535845","idStr":"3559581955535845"},"htmlText":"The latest variant BA.2 is now spreading like wild fire across the world.&nbsp; The good news is that WHO has not said yet that it is a variant of concern.&nbsp; It is supposedly 1.5 times more easily spread than Omicron.&nbsp; It is good that Novavax is getting more attention as we need all the help we can get against Covid-19!&nbsp;","listText":"The latest variant BA.2 is now spreading like wild fire across the world.&nbsp; The good news is that WHO has not said yet that it is a variant of concern.&nbsp; It is supposedly 1.5 times more easily spread than Omicron.&nbsp; It is good that Novavax is getting more attention as we need all the help we can get against Covid-19!&nbsp;","text":"The latest variant BA.2 is now spreading like wild fire across the world. The good news is that WHO has not said yet that it is a variant of concern. It is supposedly 1.5 times more easily spread than Omicron. It is good that Novavax is getting more attention as we need all the help we can get against Covid-19!","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":18,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093090033","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9093006493,"gmtCreate":1643440887130,"gmtModify":1676533821638,"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://community-static.tradeup.com/news/58fdf90023b13bdabb45b46bb0d645e1","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3583106134648492","idStr":"3583106134648492"},"htmlText":"Surprise $nvax is green.&nbsp;","listText":"Surprise $nvax is green.&nbsp;","text":"Surprise $nvax is green.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093006493","repostId":1188787478,"repostType":2,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099774200,"gmtCreate":1643438587162,"gmtModify":1676533821444,"author":{"id":"3581502897038686","authorId":"3581502897038686","name":"Grit100","avatar":"https://static.tigerbbs.com/c3c65cb20cfcce91cc07fddb27bc3ccd","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581502897038686","idStr":"3581502897038686"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099774200","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099774001,"gmtCreate":1643438463305,"gmtModify":1676533821401,"author":{"id":"4103288833797810","authorId":"4103288833797810","name":"Gagnant10","avatar":"https://static.tigerbbs.com/ff5876200a5106a94cc1f9866d3108f0","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"4103288833797810","idStr":"4103288833797810"},"htmlText":"Impress","listText":"Impress","text":"Impress","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099774001","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099757176,"gmtCreate":1643433125996,"gmtModify":1676533820955,"author":{"id":"3574636093461410","authorId":"3574636093461410","name":"thammada","avatar":"https://static.tigerbbs.com/64bd66fcccfc86b5e81286648668869b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3574636093461410","idStr":"3574636093461410"},"htmlText":"[Happy]&nbsp;","listText":"[Happy]&nbsp;","text":"[Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099757176","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099728305,"gmtCreate":1643429539670,"gmtModify":1676533820443,"author":{"id":"3582358454168309","authorId":"3582358454168309","name":"chqngchang","avatar":"https://static.tigerbbs.com/b56233832049ceeac966ba711e0e1f75","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3582358454168309","idStr":"3582358454168309"},"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099728305","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099763532,"gmtCreate":1643426515935,"gmtModify":1676533820155,"author":{"id":"3554804006357295","authorId":"3554804006357295","name":"iamateh","avatar":"https://static.tigerbbs.com/cfa6492594e288f70d24f72146aeec45","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3554804006357295","idStr":"3554804006357295"},"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099763532","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099769221,"gmtCreate":1643426273515,"gmtModify":1676533820130,"author":{"id":"3580460899282910","authorId":"3580460899282910","name":"blackant","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3580460899282910","idStr":"3580460899282910"},"htmlText":"Ok..","listText":"Ok..","text":"Ok..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099769221","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099760411,"gmtCreate":1643426181449,"gmtModify":1676533820113,"author":{"id":"3573025586175142","authorId":"3573025586175142","name":"FlorCheah","avatar":"https://static.tigerbbs.com/8cb91e5f44e414335718e1beffda39e8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573025586175142","idStr":"3573025586175142"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099760411","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099782859,"gmtCreate":1643425648351,"gmtModify":1676533820002,"author":{"id":"3582617881962608","authorId":"3582617881962608","name":"Ahsiang","avatar":"https://static.tigerbbs.com/310f96e7696af85ae33ece774a483d15","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3582617881962608","idStr":"3582617881962608"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099782859","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9099719591,"gmtCreate":1643423782822,"gmtModify":1676533819597,"author":{"id":"3573374991554107","authorId":"3573374991554107","name":"sinoob","avatar":"https://static.tigerbbs.com/c7aa6e79d10d30e6c542fe5787c2a09d","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3573374991554107","idStr":"3573374991554107"},"htmlText":"Happy weekend! Come like like comment comment tqtq kam siah kam siah&nbsp;","listText":"Happy weekend! Come like like comment comment tqtq kam siah kam siah&nbsp;","text":"Happy weekend! Come like like comment comment tqtq kam siah kam siah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099719591","repostId":1188787478,"repostType":4,"repost":{"id":"1188787478","kind":"news","pubTimestamp":1643423060,"share":"https://ttm.financial/m/news/1188787478?lang=&edition=fundamental","pubTime":"2022-01-29 10:24","market":"us","language":"en","title":"Why Novavax Stock Surged 14% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1188787478","media":"Motley Fool","summary":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in th","content":"<html><head></head><body><p>Any time there&#39;s a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock <a href=\"https://laohu8.com/S/NVAX\"><b>Novavax</b></a> to a nearly 14% gain on Friday.</p><p>So what</p><p>The deal is an advance purchase agreement between Novavax and Israel&#39;s Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company&#39;s NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.</p><p>The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech <b>Moderna</b>&#39;s mRNA-1273 (Spikevax) and Comirnaty from <b>Pfizer</b> and <b>BioNTech</b>.</p><p>In its press release on the matter, Novavax wrote that it &#34;will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.&#34;</p><p>The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than &#34;original&#34; omicron.</p><p>Now what</p><p>Novavax is certainly a scrappy competitor in the &#34;Global Coronavirus Vaccine Contest.&#34; Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn&#39;t giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world&#39;s coronavirus-fighting arsenal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Surged 14% on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Surged 14% on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-29 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2022/01/28/why-novavax-stock-surged-14-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188787478","content_text":"Any time there's a notable development with the coronavirus, shares of vaccine makers involved in the fight against it tend to rise. That, combined with the announcement of a new supply deal, helped push coronavirus stock Novavax to a nearly 14% gain on Friday.So whatThe deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. Under its terms, the Middle Eastern nation will take 5 million doses of the company's NVX-CoV2373 and holds an option for 5 million more. The financial particulars of the deal were not disclosed.The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellowbiotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech.In its press release on the matter, Novavax wrote that it \"will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israelpending regulatory approval.\"The news comes amid reports of a new variant of the coronavirus similar to omicron. The officially titled omicron BA.2 has been detected in several U.S. states, including California and Texas. Information is still somewhat sparse about it; early findings seem to indicate it might be slightly more transmissible than \"original\" omicron.Now whatNovavax is certainly a scrappy competitor in the \"Global Coronavirus Vaccine Contest.\" Comirnaty and mRNA-1273 are the clear front-runners in many regions, but Novavax isn't giving up on being a major jab supplier too. The signing of a new, top-level supply agreement is indisputably good news and makes NVX-CoV2373 an increasingly useful weapon in the world's coronavirus-fighting arsenal.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":347,"commentSize":20,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}